U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07189858) titled 'Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada' on Sept. 11.
Brief Summary: This is a Phase 4 multi-center, group-randomized, crossover trial to compare nasal antimicrobial photodisinfection therapy (aPDT) with standard of care for prevention of surgical site infections in patients undergoing major elective, urgent, or emergent surgeries in a hospital setting. The main outcomes are to:
1. compare the efficacy, and
2. estimate the safety of applying nasal (aPDT) before surgery in reducing the incidence of SSIs within the initial 30 days after surgery compared to standard of care (SOC).
Particip...